Drugs / JV-394
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07382817 | Feb 2026 → Dec 2029 expected | neoplasm | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JV-394 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07382817 ↗ |
| Modality | Cell therapy | “a type of autologous CAR-T cell therapy” NCT07382817 ↗ |
| Route | Other | “Given by infusion” NCT07382817 ↗ |